Immune Effector Cell Associated Encephalopathy (ICE) TOOL

Loading...

Orientation to year, month, city, hospital

Ability to name 3 objects

Ability to write a standard sentence

Ability to count backwards from 100 by 10

References

Anna Fleischer. Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies.. Journal for immunotherapy of cancer, 2024
M. Wehrli. Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS). Journal for Immunotherapy of Cancer, 2022
P J Hayden. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).. Annals of oncology : official journal of the European Society for Medical Oncology, 2021
B. Santomasso. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline. Journal of Clinical Oncology, 2021
M. Pennisi. Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.. Blood advances, 2020